These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38000510)

  • 1. Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti.
    Matias WR; Guillaume Y; Cene Augustin G; Vissieres K; Ternier R; Slater DM; Harris JB; Franke MF; Ivers LC
    Int J Infect Dis; 2024 Feb; 139():153-158. PubMed ID: 38000510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis.
    Ivers LC; Hilaire IJ; Teng JE; Almazor CP; Jerome JG; Ternier R; Boncy J; Buteau J; Murray MB; Harris JB; Franke MF
    Lancet Glob Health; 2015 Mar; 3(3):e162-8. PubMed ID: 25701994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.
    Franke MF; Jerome JG; Matias WR; Ternier R; Hilaire IJ; Harris JB; Ivers LC
    Vaccine; 2017 Oct; 35(43):5819-5827. PubMed ID: 28916247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case-control study in Lusaka, Zambia.
    Sialubanje C; Kapina M; Chewe O; Matapo BB; Ngomah AM; Gianetti B; Ngosa W; Kasonde M; Musonda K; Mulenga M; Michelo C; Sinyange N; Bobo P; Zyambo K; Mazyanga L; Bakyaita N; Mukonka VM
    BMJ Open; 2022 Nov; 12(11):e066945. PubMed ID: 36368745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future cholera vaccines.
    Shaikh H; Lynch J; Kim J; Excler JL
    Vaccine; 2020 Feb; 38 Suppl 1():A118-A126. PubMed ID: 31879125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
    Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
    Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Burnett EM; Francois J; Sreenivasan N; Wannemuehler K; Faye PC; Tohme RA; Delly P; Deslouches YG; Etheart MD; Dismer AM; Patel R; Date K
    Vaccine; 2019 Oct; 37(43):6348-6355. PubMed ID: 31521413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Household and Individual Risk Factors for Cholera among Cholera Vaccine Recipients in Rural Haiti.
    Matias WR; Teng JE; Hilaire IJ; Harris JB; Franke MF; Ivers LC
    Am J Trop Med Hyg; 2017 Aug; 97(2):436-442. PubMed ID: 28722575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with diarrheal disease among children aged 1-5 years in a cholera epidemic in rural Haiti.
    Dolstad HA; Franke MF; Vissieres K; Jerome JG; Ternier R; Ivers LC
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009726. PubMed ID: 34679083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up.
    Sévère K; Rouzier V; Anglade SB; Bertil C; Joseph P; Deroncelay A; Mabou MM; Wright PF; Guillaume FD; Pape JW
    Am J Trop Med Hyg; 2016 May; 94(5):1136-42. PubMed ID: 26928838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
    Aibana O; Franke MF; Teng JE; Hilaire J; Raymond M; Ivers LC
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2576. PubMed ID: 24278498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.
    Baik YO; Choi SK; Olveda RM; Espos RA; Ligsay AD; Montellano MB; Yeam JS; Yang JS; Park JY; Kim DR; Desai SN; Singh AP; Kim IY; Kim CW; Park SN
    Vaccine; 2015 Nov; 33(46):6360-5. PubMed ID: 26348402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study.
    Lee EC; Chao DL; Lemaitre JC; Matrajt L; Pasetto D; Perez-Saez J; Finger F; Rinaldo A; Sugimoto JD; Halloran ME; Longini IM; Ternier R; Vissieres K; Azman AS; Lessler J; Ivers LC
    Lancet Glob Health; 2020 Aug; 8(8):e1081-e1089. PubMed ID: 32710864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
    Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
    Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.
    Elias Chitio JJ; Baltazar CS; Langa JP; Baloi LD; Mboane RBJ; Manuel JA; Assane S; Omar A; Manso M; Capitine I; Van Rensburg C; Luiz N; Mogasale V; Marks F; Park SE; Beck NS
    BMJ Open; 2022 Sep; 12(9):e053585. PubMed ID: 36547726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.
    Azman AS; Luquero FJ; Ciglenecki I; Grais RF; Sack DA; Lessler J
    PLoS Med; 2015 Aug; 12(8):e1001867. PubMed ID: 26305226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Evaluation of a Government-Conducted Oral Cholera Vaccination Campaign-Haiti, 2013.
    Routh JA; Sreenivasan N; Adhikari BB; Andrecy LL; Bernateau M; Abimbola T; Njau J; Jackson E; Juin S; Francois J; Tohme RA; Meltzer MI; Katz MA; Mintz ED
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):37-42. PubMed ID: 29064362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oral cholera vaccine in Haiti: a rural demonstration project.
    Ivers LC; Teng JE; Lascher J; Raymond M; Weigel J; Victor N; Jerome JG; Hilaire IJ; Almazor CP; Ternier R; Cadet J; Francois J; Guillaume FD; Farmer PE
    Am J Trop Med Hyg; 2013 Oct; 89(4):617-624. PubMed ID: 24106187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
    Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.